Literature DB >> 11092664

Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy.

J Narula1, M S Dawson, B K Singh, A Amanullah, E R Acio, F A Chaudhry, R B Arani, A E Iskandrian.   

Abstract

OBJECTIVES: We evaluated a novel protocol of dual-isotope, gated single-photon emission computed tomographic (SPECT) imaging combined with low and high dose dobutamine as a single test for the characterization of various types of altered myocardial dysfunction.
BACKGROUND: Myocardial perfusion tomography and echocardiography have been used separately for the assessment of myocardial viability. However, it is possible to assess perfusion, function and contractile reserve using gated SPECT imaging.
METHODS: We studied 54 patients with ischemic cardiomyopathy using rest and 4 h redistribution thallium-201 imaging and dobutamine technetium-99m sestamibi SPECT imaging. The sestamibi images were acquired 1 h after infusion of the maximal tolerated dose of dobutamine and again during infusion of dobutamine at a low dose to estimate contractile reserve. Myocardial segments were defined as hibernating, stunned, remodeled or scarred.
RESULTS: Severe regional dysfunction was present in 584 (54%) of 1,080 segments. Based on the combination of function and perfusion characteristics in these 584 segments, 24% (n = 140) were labeled as hibernating; 23% (n = 136) as stunned; 30% (n = 177) as remodeled; and 22% (n = 131) as scarred. Contractile reserve, represented by improvement in wall motion/thickening by low dose dobutamine, was observed in 83% of stunned, 59% of hibernating, 35% of remodeled and 13% of scarred myocardial segments (p<0.05).
CONCLUSIONS: It is possible with this new imaging technique to characterize dysfunctional myocardium as stunned, hibernating, remodeled and nonviable. These subtypes often coexist in the same patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092664     DOI: 10.1016/s0735-1097(00)00959-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  Left main disease diagnosis: The Achilles heel or the great strength of modern cardiac imaging?

Authors:  Aiden Abidov
Journal:  J Nucl Cardiol       Date:  2015-10-30       Impact factor: 5.952

2.  Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium.

Authors:  Brian R Weil; Gen Suzuki; Merced M Leiker; James A Fallavollita; John M Canty
Journal:  Circ Res       Date:  2015-08-13       Impact factor: 17.367

3.  FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.

Authors:  C M C van Campen; Frans C Visser; Arno P van der Weerdt; Paul Knaapen; Emile F I Comans; Adriaan A Lammertsma; Carel C de Cock; Cees A Visser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-26       Impact factor: 9.236

4.  Single injection, double acquisition: a double-edged sword?

Authors:  Ernst E van der Wall; Yves G America; Arthur J Scholte; Jeroen J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-24       Impact factor: 2.357

5.  Characterizing preclinical model of ischemic heart failure: difference between LAD and LCx infarctions.

Authors:  Michael G Katz; Anthony S Fargnoli; Andrew P Kendle; Charles R Bridges
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-15       Impact factor: 4.733

6.  Prediction of left ventricular wall motion recovery after acute myocardial infarction by Tl-201 gated SPECT: incremental value of integrated contractile reserve assessment.

Authors:  Marcus Vinicius Simões; Oswaldo César de Almeida-Filho; Antonio Osvaldo Pintya; Alexandre Baldini de Figueiredo; Cleide Marques Antloga; Fernando Vilela Salis; Nadia de Paula Batista; Moysés de Oliveira Lima-Filho; Benedito Carlos Maciel; José Antonio Marin-Neto
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

7.  Elimination of ischemic mitral regurgitation does not alter long-term left ventricular remodeling in the ovine model.

Authors:  Kanji Matsuzaki; Masato Morita; Hirotsugu Hamamoto; Mio Noma; J Daniel Robb; Matthew J Gillespie; Joseph H Gorman; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

8.  Direct epicardial mapping can differentiate hibernating from scarred myocardium: a validation study with 18F-FDG-PET.

Authors:  Christian Vahlhaus; Michael Schäfers; Hans-Jürgen Bruns; Frauke Janssen; Jörg Stypmann; Dieter Hammel; Hans H Scheld; Otmar Schober; Günter Breithardt; Thomas Wichter
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

9.  The impact of viability assessment using myocardial perfusion imaging on patient management and outcome.

Authors:  Fadi G Hage; Rajesh Venkataraman; Wael Aljaroudi; Paco E Bravo; Joel McLarry; Michael Faulkner; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-02-26       Impact factor: 5.952

10.  Quantifying acute myocardial injury using ratiometric fluorometry.

Authors:  Mahsa Ranji; Muneaki Matsubara; Bradley G Leshnower; Robin H Hinmon; Dwight L Jaggard; Britton Chance; Robert C Gorman; Joseph H Gorman Iii
Journal:  IEEE Trans Biomed Eng       Date:  2008-10-31       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.